HuPK Highlights for EU Symposium
Read Flipbook
Advances and Applications of Humanized In Vivo Models in Preclinical Drug Development
JAX presented in a European tour in 4 cities to demonstrate how the immunotherapy pipeline can benefit from the expertise of JAX, a major player in the in vivo preclinical pharmacology space. We are discussing why humanized mice are becoming the golden standard for preclinical immunotherapy development.
-
-
Humanized Mice Highlights for EU Symposium
Read Flipbook
-
CRS Highlights for EU Symposium
Read Flipbook
-
Loading, please wait
Error - something went wrong!
Ready to discuss your project needs with our experts?
Thank you, we will be in touch soon!
-
FcRn model platform
The FcRn platform from The Jackson Laboratory mimics specific aspects of the human IgG physiology providing the ideal model platform to assess the pharmacokinetics (PK) of therapeutic antibody candida
Watch Video
-
Use of FcRn Transgenic mice for drug discovery of therapeutic antibodies with Roche's Michael Otteneder, PhD
Watch Video
-
Evidence-based selection of the starting dose in first-in-human clinical trials using humanized mouse models
The dose selection for first-in-human (FIH) clinical trials relies on data obtained by a combination of in vitro and in vivo studies designed to evaluate the efficacy, toxicity, and stability of...
Learn More
-
In Vivo Evaluation of Bispecific T-Cell Engager Efficacy and Safety
Read Flipbook
-
In vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies
Read Flipbook
-
Achieving Relevant Preclinical Characterization of CAR T Cell Therapies
This whitepaper examines the constraints and challenges inherent in each CAR T study type and how to overcome them with in vivo studies using fully humanized mouse models.
Read Flipbook
-
CRS Studies for CAR T Cell Therapy
Review JAX’s CRS evaluation capabilities and see how a CRS study can help move your CAR T therapeutic into the clinic faster, safer, and more confidently.
Read Flipbook
-
The Humanized FcRn Platform: An Essential Tool for Preclinical PK Assessment of Therapeutic Antibody Candidates
Greg Christianson, Study Director, In Vivo Services, The Jackson Laboratory speaks about the use of human FcRn transgenic mouse models to select antibody therapeutic candidates with optimum pharmacoki
Watch Video
-
Targeting Natural Killer Cell Activity with Humanized NSG IL-15 Mouse Model
The NEW cord blood CD34+ HSC humanized NSG-IL15 mouse enables efficacy research for compounds targeting human natural killer (NK) cell activity including antibody-dependent cellular cytotoxicity.
Read Flipbook
-
JAX Guide: Assessing Antibody Pharmacokinetics Using the JAX FcRn Platform
Read Flipbook
-
Humanized NSG Mouse Models
CD34 and PBMC humanized NSG mice are powerful preclinical models for studying the actions of immuno-modulators, either alone or in combination with other treatments.
Read Flipbook
